Vanguard Global Advisers »

Pacira Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 84k 22.60

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Pacira Pharmaceuticals

BlackRock
Vanguard Group
Doma Perpetual Capital Management
Vanguard Portfolio Management
Dimensional Fund Advisors
D. E. Shaw & Co
Renaissance Technologies
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
Morgan Stanley
American Century Companies
Geode Capital Management
Citadel Advisors
Impax Asset Management Group

View all funds holding Pacira Pharmaceuticals